Premium
Changes in quality of life in patients with low‐flow aortic stenosis undergoing transcatheter aortic valve replacement
Author(s) -
Ahmed Aisha,
Alsidawi Said,
Bae Richard,
Cavalcante Joao,
Fukui Miho,
Gössl Mario,
Sorajja Paul,
Garcia Santiago
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28805
Subject(s) - medicine , stenosis , cardiology , quality of life (healthcare) , valve replacement , ejection fraction , aortic valve stenosis , stroke volume , aortic valve replacement , aortic valve , heart failure , nursing
Background We sought to quantify and compare changes in quality of life measures after transcatheter aortic valve replacement (TAVR) in patients with low‐flow (LF) and normal‐flow (NF) aortic stenosis (AS). Methods We included 297 patients treated with TAVR at Abbott Northwestern Hospital from January 2015 to October 2017. Health status was assessed at baseline and 30 days post‐procedure using the Kansas City Cardiomyopathy Questionnaire 12 (KCCQ‐12). Overall (KCCQ‐OS) and domain‐specific (physical limitation, symptom frequency, quality of life, and social limitation) scores were compared in three subsets of patients as defined by stroke volume index (≤ or >35 ml/m 2 ), ejection fraction (EF) (≤ or >40%), and mean gradient (≤ or >40 mmHg). Results Of the 297 patients included, 129 (43%) had NF high‐gradient (NF AS group) and 168 (56%) had LF severe AS, including 25 (8%) with low EF (8%) (“Classical” low‐flow low‐gradient LEF [LF‐LG‐LEF] group) and 143 (48%) with preserved EF (“Paradoxical” LF‐LG group). At baseline, patients with LF‐LG‐LEF AS had more severe impairment in symptoms frequency ( p = .06) but similar KCCQ‐OS. At 1‐month after TAVR, all groups had moderate improvements in quality of life (Delta KCCQ‐OS: “Classical” LF‐LG‐LEF 18 ± 21, paradoxical AS 14 ± 18, and NF AS 15 ± 16, p = .57). During a median follow‐up time of 2.4 years, there was no difference in mortality ( p = .34) but patients with paradoxical LF‐LG AS had a higher risk of rehospitalization for heart failure ( p = .01). Conclusions Patients with LF severe AS derive significant improvements in quality of life measures after TAVR, indistinguishable from patients with NF AS.